Ekspresi mRNA LMP2A Epstein-Barr Virus dari Biopsi Jaringan dalam Blok Parafin Berpotensi sebagai Biomarka dalam Diagnosis Karsinoma Nasofaring

Roni Afriansya; Hendro Pramono; Hidayat Sulistyo; Daniel Joko Wahyono

doi:10.20884/1.mib.2016.33.3.323

Ekspresi mRNA LMP2A Epstein-Barr Virus dari Biopsi Jaringan dalam Blok Parafin Berpotensi sebagai Biomarka dalam Diagnosis Karsinoma Nasofaring

Roni Afriansya⁽¹⁾ , Hendro Pramono⁽²⁾ , Hidayat Sulistyo⁽³⁾ , Daniel Joko Wahyono⁽⁴⁾

⁽¹⁾ Fakultas Biologi
⁽²⁾ Fakultas Biologi Unsoed
⁽³⁾ Fakultas Kedokteran Unsoed
⁽⁴⁾ Fakultas Biologi Unsoed

DOI: 10.20884/1.mib.2016.33.3.323

Abstrak

Karsinoma nasofaring (KNF) merupakan tumor epitel yang terletak di nasofaring dan merupakan penyakit genetik multifaktor yang endemik. Penyebab utama KNF adalah infeksi oleh Virus Epstein-Barr (EBV). Keberadaan EBV pada penderita KNF dapat diketahui dengan ditemukannya DNA EBV dalam spesimen biopsi jaringan penderita KNF. Genom EBV dan ekspresi sebagian dari produk gen laten virus secara konsisten terdeteksi hampir di setiap sel dalam kanker ini, salah satunya adalah gen Latent Membrant Protein (LMP). Aktivitas mRNA EBV lebih mencerminkan patogenesis KNF yang sesungguhnya dari pada diagnosis serologi dan pengukuran DNA EBV di sirkulasi. Penelitian dilakukan di Laboratorium PA RSUD Margono Seokarjo, Purwokerto/Lab PA Fakultas Kedokteran dan laboratorium genetika/molekuler Universitas Jenderal Soedirman Purwokerto. Analisis Ekspresi mRNA LMP2A EBV dengan teknik one step RT-PCR dan produk RT-PCR (amplikon cDNA) divisualisasi dengan elektroforesis gel agarosa 1%. Hasil ekspresi mRNA LMP2A EBV adalah 27,3% (6 dari 22 sampel). Kesimpulan, metode one step RT-PCR dapat digunakan untuk menganalisis ekspresi mRNA LMP2A EBV dari sampel biopsi jaringan KNF dalam blok paraffin dan hasil positivitas ekspresi mRNA LMP2A EBV sedang, sehingga berpotensi digunakan sebagai petanda biologi molekul diagnosis KNF.

Teks Lengkap:

PDF

Referensi

Adham, M., Kurniawan, A.N., Muhtadi, A.I., Roezin, A., Hermani, B., Gondhowiardjo, S., Tan, I.B., Middeldorp, J.M. 2012. Nasopharyngeal Carcinoma in Indonesia: Epidemiology, Incidence, Signs, and Symptoms at Presentation. Chinese Journal Cancer 31(4): 185-196.

Brooks, L., Yao, Q.Y., Rickinson, A.B., and Young, L.S. 1992. Epstein-Barr Virus Latent Gene Transcription in Nasopharyngeal Carcinoma Cells: Coexpression of EBNA1, LMP1, and LMP2 Transcripts. Journal of virology 66(5): 2689-2697.

Busson, P., McCoy, R., Sadler, R., Gilligan, K., Tursz, T., Raab-Traub, N. 1992. Consistent Transcription of the Epstein-Barr Virus LMP2 Gene in Nasopharyngeal Carcinoma. Journal of virology 66(5): 3257-3262.

Catts, V. S., Catts, S. V., Fernandez, H. R., Taylor, J. M., Coulson, E. J., and Lutze-Mann, L. H. 2005. A Microarray Study of Post-mortem mRNA Degradation in Mouse Brain Tissue. Molecular brain research 138(2): 164-177.

Chu, W.S., Furusato, B., Wong, K., Sesterhenn, I.A., Mostofi, F.K., Wei, M.Q., Zhu, Z., Abbondanzo, S.L., Liang, Q. 2005. Ultrasound-accelerated Formalin Fixation of Tissue Improves Morphology, Antigen and mRNA Preservation. Modern pathology 18(6): 850-863.

Dawson, C.W., Port, R.J., Young, L.S. 2012. The Role of The EBV-encoded Latent Membrane Proteins LMP1 and LMP2 in The Pathogenesis of Nasopharyngeal Carcinoma (NPC). Seminar in Cancer Biology 22(2): 144-153.

Fles, R., M.A.Wildemen., Beni S., Sofia, M.H., I. Bing, T. 2010. Knowledge of General Practitioners About Nasopharyngeal Cancer at The Puskesmas in Yogyakarta, Indonesia. BioMed Central Medical Education 10(81): 1-6.

Gu, A.D., Zeng, M.S., Qian, C.N. 2012. The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation. International Journal of Molecular Sciences 13(10): 13737-13747.

Jarzab, M., Rozanowski, P., Kowalska, M., Zebracka, J., Rudnicka, L., Stobiecka E., Jarzab,B., Stachura, J. Pawlega, J. 2008. Optimization of the Method of RNA Isolation from Paraffin Blocks to Assess Gene Expression in Breast Cancer. Polish Journal of Pathology 59(2): 85–91.

Jian, G.T., Xuan, I., Ping, C. 2004. Expression of Matrix Metallo-proteinase-9 in Nasopharyngeal Carcinoma and Associated with Epstein Barr Virus Infection. Journal of Zheijiang University Sciences 5(10): 1304-1412.

Lahr, G., Starzinski-Powitz, A. and Mayer, A. 2002. Analysis of Specific Gene Expression. In: Conn PM (Ed). Methods in Enzymology 356: 271–281. Academic Press, San Diego, USA.

Liu, M.T., Hsieh, C.Y., Chang, T.H., Lin, J.P., Huang, C.C., Wang, A.J. 2003. Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma. Japanese Journal of Clinical Oncology 2(10): 501-508.

Lu, J., Cooper, J.S., M. Lee Anne W.M. 2010. The Epidemiology of Nasopharyngeal Carcinoma. In: Nasopharyngeal Cancer. Berlin: Springer 1-9.

Nakaya, T., Kikuchi, Y., Kunita, A., Ishikawa, S., Matsusaka, K., Hino, R., Aburatani, H., Fukayama, M. 2013. Enrichment of Stem-like Cell Population Comprises Transformation Ability of Epstein-Barr Virus Latent Membrane Protein 2A for Non-transformed Cells. Virus Research 174(1-2): 108-115.

Ma, J., Liu, L., Tang, L., Zong, J., Lin, A., Lu, T., Cui, N., Cui, C., Li, L. 2007. Retropharyngeal Lymphnode Metastasis in Nasopharyngeal Carcinoma: Prognostic Value and Staging Categories. Clinical Cancer Research 13(5): 1445-1452.

Munir, D.,Lutan, R., Hasibuan, M., Henny, F. 2007. Ekspresi Protein p53 Mutan pada Karsinoma Nasofaring. Majalah Kedokteran Nusantara 40(3): 167-172.

Mutiarangura A, Tanuyuttwongesse C, Porthanakasem W, Kerkhanjanarong V, Sriuranphong V. 1997. Genomic Alterations in Nasopharyngeal Carcinoma; Loss of Heterozygosity an Epstein-Barr Virus Infection. Journal Cancer 76: 770-776.

Pittaluga, S., Loke, S.L., So, K.C., Cheung, K.N., Ma, L. 1992. Clonal Epstein–Barr Virus in Lymphoepithelioma-like Carcinoma of the Stomach: Demonstration of Viral Genome by in Situ Hybridization and Southern Blot Analysis. Modern Pathology 5(6): 661–664.

Raab-Traub N., and Flynn K., 1986. The Structure of The Termini of The Epstein–Barr Virus as a Marker of Clonal Cellular Proliferation. Cell 47(6): 883–889.

Shen, Y., Zhang, S., Sun, R., Wu, T., Qian, J. 2015.Understanding the Interplay Between Host Immunity and Epstein-Barr Virus in NPC Patients. Emerging Microbes Infections 4(20): 1-9.

Stevens, S. J., Verkuijlen, S. A., Hariwiyanto, B., Harijadi., Paramita, D.K., Fachiroh, J., Adham, M., Tan, I.B., Haryana, S.M., Middeldorp, J.M. 2006. Noninvasive Diagnosis of Nasopharyngeal Carcinoma: Nasopharyngeal Brushings Reveal High Epstein‐Barr Virus DNA Load and Carcinoma‐specific Viral BARF1 mRNA. International journal of cancer 119(3): 608-614.

Tang, L., Li, L., Mao, Y., Liu, L., Liang, S., Chen, Y., Sun, Y., Liao, X., Tian, L., Lin, A., Liu, M., Ma, J. 2008. Retropharyngeal Lymphnode Metastasis in Nasopharyngeal Carcinoma Detected by Magnetic Resonance Imaging: Prognostic Value and Staging Categories. Cancer 113(2): 347-354.

Wildeman, M.A., Renske, F., Marlinda, A., Ika, D.M., Ilse, L., Mara, S., Andrew, D.V., Faiziah, F., Zanil, M., Armiyanto., Middledorp, J.M., Geertin, G., Ronny, S., Tan, I.B. 2012. Short-term Effect of Different Teaching Methods on Nasopharyngeal Carcinoma for General Practicioners in Jakarta, Indonesia. PLoS ONE 7(3): 1-7